Wagner Sotalol-WGR

Wagner Sotalol-WGR is a prescription medication containing sotalol hydrochloride, used primarily for managing heart rhythm disorders. The Wagner brand is a well-known healthcare and pharmaceutical label in Australia and New Zealand, historically associated with various health products and generic medications.

Manufacturing of Wagner branded pharmaceuticals often occurs across multiple international locations depending on the specific supply chain and active ingredient sourcing, often adhering to TGA standards for the Australian market. The brand is currently managed under the umbrella of Probiotec Limited, an Australian manufacturer and packer of pharmaceutical and consumer products. In 2024, Indonesia's PT Pyridam Farma Tbk completed the acquisition of Probiotec, marking a shift in the ultimate ownership to an Indonesian-headquartered entity while maintaining operations and distribution focused on the Australasian healthcare sector.